TempraMed Signs Exclusive UK Distribution Agreement with Poole Bay Holdings for VIVI Epi(TM), Targeting School Networks Across the UK
Two-year agreement and approximately US$198,000 in potential purchases while opening established UK first-aid, medical-supply, workplace and education channels
Highlights
- Definitive agreement signed October 28, 2026 appoints Poole Bay Holdings Ltd. as exclusive UK distributor of VIVI Epi™ for an initial 24-month term, subject to UK regulatory requirements.

